IPI trademark

AMYLOCARE haTTR-Amyloidose Patientenservice

RegisteredIPIWord and designClass 44Class 45

"AMYLOCARE haTTR-Amyloidose Patientenservice" is a word and design mark owned by Alnylam Pharmaceuticals, Inc., filed at the IPI on October 5, 2018. It is registered and covers classes 44 and 45.

View Alnylam Pharmaceuticals, Inc. portfolioGet this data via the API
Official IPI record
AMYLOCARE haTTR-Amyloidose Patientenservice trademark as filed
As filed with the IPI
Status
Registered
Filed
October 5, 2018
Registered
May 20, 2019
Expires
October 5, 2028
Application no.
79676/2018
Registration no.
731302
Office
IPI
Swiss Federal Institute of Intellectual Property
Mark type
Word and design
2 classes
Ownership

Who owns AMYLOCARE haTTR-Amyloidose Patientenservice

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Alnylam Pharmaceuticals, Inc.

ALNY · United States

69 trademarks in the portfolioView company

Representative

M. Zardi & Co. SA

Goods and services

What the mark covers

The products and services AMYLOCARE haTTR-Amyloidose Patientenservice is filed for, grouped by Nice class.

  • Servizi di cure (non mediche) personali domiciliari per l'assistenza nelle attività quotidiane, ovvero servizi di assistenza infermieristica a domicilio; servizi di supporto domiciliare per pazienti affetti da amiloidosi ereditaria ATTR (hATTR), ovvero servizi di assistenza sanitaria domestica; fornitura di servizi di supporto personale per pazienti affetti da amiloidosi ereditaria ATTR (hATTR) e alle loro famiglie, ovvero servizi di assistenza psicologica.

  • Fornitura di servizi di supporto personale per pazienti affetti da amiloidosi ereditaria ATTR (hATTR) e alle loro famiglie, ovvero fornitura di supporto emotivo.

History

What has happened so far

Steps recorded by the IPI, newest first.

  1. Registration
FAQ

About AMYLOCARE haTTR-Amyloidose Patientenservice

Who owns the trademark "AMYLOCARE haTTR-Amyloidose Patientenservice"?

The IPI trademark "AMYLOCARE haTTR-Amyloidose Patientenservice" (application 79676/2018) is owned by Alnylam Pharmaceuticals, Inc.

What is the status of "AMYLOCARE haTTR-Amyloidose Patientenservice"?

Its status at the IPI is: registered.

When was "AMYLOCARE haTTR-Amyloidose Patientenservice" registered?

It was registered on May 20, 2019 and is due to expire on October 5, 2028.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull AMYLOCARE haTTR-Amyloidose Patientenservice and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019ebbc0-c27e-7524-9ac7-a2b3cadfb845
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019ebbc0-c27e-7524-9ac7-a2b3cadfb845",
  "object": "trademark",
  "mark_text": "AMYLOCARE haTTR-Amyloidose Patientenservice ((fig.))",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "CH",
  "application_number": "79676/2018",
  "filing_date": "2018-10-05",
  "nice_classes": [
    44,
    45
  ],
  "owners": [
    {
      "name": "ALNYLAM PHARMACEUTICALS, INC.",
      "entity_id": "ent_019eb709-7d9a-70dc-b19d-2c56e8a223b5"
    }
  ]
}